Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Forced Transdifferentiation01:28

Forced Transdifferentiation

2.5K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.5K
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comprehensive Summary of the Third International StemNet Meeting 2026.

Frontiers in bioscience (Landmark edition)·2026
Same author

Cord blood-derived mesenchymal stromal cells in children with steroid-dependent nephrotic syndrome: a prospective phase II study.

Clinical kidney journal·2026
Same author

Interleukin-8 and extracellular vesicles spread senescence in Lymphangioleiomyomatosis microenvironment.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

SAFESLOT: an experimental virtual reality protocol to examine flow, craving, and cognitive biases in gambling.

Frontiers in psychiatry·2026
Same author

<i>In Vitro</i> Study of Triiodothyronine Effects on C57B6J Mesenchymal Stem Cells Isolated from Bone Marrow and Adipose Tissue.

Stem cells and development·2026
Same author

Rheological and biochemical comparison of cord and adult blood red cells for transfusion applications.

Scientific reports·2026

Related Experiment Video

Updated: Apr 4, 2026

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.5K

How we make cell therapy in Italy.

Tiziana Montemurro1, Mariele Viganò1, Silvia Budelli1

  • 1Cell Factory, Unit of Cell Therapy and Cryobiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Drug Design, Development and Therapy
|August 29, 2015
PubMed
Summary
This summary is machine-generated.

New advanced therapy medicinal products are crucial for aging populations and degenerative diseases. This paper details establishing a hospital facility for compliant cell therapy manufacturing and quality control.

Keywords:
advanced therapy medicinal productgood manufacturing practicesstem cells

More Related Videos

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
09:30

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Published on: December 5, 2025

688
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.9K

Related Experiment Videos

Last Updated: Apr 4, 2026

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.5K
Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
09:30

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Published on: December 5, 2025

688
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.9K

Area of Science:

  • Pharmaceutical Sciences
  • Regenerative Medicine
  • Biotechnology

Background:

  • Increasing prevalence of degenerative disorders and an aging population necessitate novel therapeutic strategies.
  • Advanced therapy medicinal products (ATMPs), including cellular, gene, and tissue-engineered products, represent a new class of drugs.
  • Manufacturing ATMPs requires adapting industrial processes to the unique characteristics of cell-containing products within a pharmaceutical framework.

Purpose of the Study:

  • To describe the establishment of a pharmaceutical-grade facility for cell therapy production in a public hospital setting.
  • To share solutions for ensuring cell therapy compliance with medicinal product manufacturing and quality control standards.
  • To address the challenges of large-scale cell-containing product manufacturing.

Main Methods:

  • Development and implementation of pharmaceutical-grade manufacturing processes for cell-based therapies.
  • Establishment of rigorous quality control protocols tailored for cell-containing medicinal products.
  • Adaptation of industrial manufacturing principles to a hospital-based facility.

Main Results:

  • Successful creation of a functional pharmaceutical-grade facility within a public hospital.
  • Demonstration of a viable approach for producing high-standard cell therapy medicinal products.
  • Identification of key solutions for regulatory compliance in cell therapy manufacturing.

Conclusions:

  • Hospital-based facilities can successfully implement pharmaceutical-grade manufacturing for advanced therapy medicinal products.
  • Standardized production and quality control are essential for the safe and effective use of cell therapies.
  • This approach provides a model for other institutions facing similar challenges in cell therapy development.